


60ish Seconds with Steve Monroe: The Coming Seniors Housing Shortage?
The Wall Street Journal just came out with a story about the coming seniors housing shortage. Unfortunately, it started with misinformation, when it stated that “seniors housing has been one of the biggest disappointments for commercial real estate investors.” In some periods yes, but in other periods not at all, when it has had outsized returns and beat the other sectors. It is all about context, and the writer should have known better. The story may, however, generate some investment interest. We are glad that occupancy has reached pre-pandemic levels, but we really need to get to 2017 levels to be happy. Remember, back in October 2020 we did the analysis and concluded it would take at... Read More »
60-ish Seconds with Steve Monroe: Becoming a Statistic
I became an industry statistic last week, although not intentionally. While returning from the annual ASHA meeting in Phoenix last Wednesday, I developed a slight cough just before takeoff, which turned into a full-blown cough by landing. The next day I went to my PCP to get some drugs, and tested negative for flu, COVID and RSV. By late Friday afternoon, I was miserable. My daughter happened to be home, and seeing me struggle up the stairs, then fall at the top, unable to get up or even roll over, and then drag me into my bedroom, she made a call to a health care provider. The provider videochatted with me for less than a minute and then told my daughter to call 911 immediately. The... Read More »
60 Seconds with Swett: Rising Treasuries and Senior Care M&A
Momentum in the M&A market has continued into 2025, and there is general optimism that the new Administration that descended on Washington this week will be good for the business environment. Although there is some uncertainty around what, if any, tariffs are enacted and whether their effect on prices would potentially be blunted by falling energy costs and efficiency efforts, assuming “drill baby drill” and “DOGE” have a near-immediate effect. And we don’t know about the scale of the deportations and its impact on wages. However, if M&A activity started to take off last year due to the expectation of lower interest rates, then what effect will the 10-Year Treasury rate shooting... Read More »60 Seconds with Swett: 2025 Set for Healthcare M&A Growth
The word from the JP Morgan Healthcare Conference, which kicked off in San Francisco this week, is that M&A activity in the biopharma/life sciences space will likely grow in 2025 after a relative downturn in 2024. A more business-friendly administration in D.C. combined with an enormous amount of dry powder set to do deals, including some bigger billion-dollar-plus ones too. Indeed, our own M&A data from LevinPro HC, which tracks all the healthcare services and tech deals, showed the 2024 total decline to just under 2,000 deals for the year, a 10% decrease from 2023’s activity and a 19% decrease from 2022’s. Dollar volume also dropped below $200 billion in total disclosed purchase... Read More »